Kodiak Sciences, Inc. (KOD)
99.26
-0.61
(-0.61%)
USD |
NASDAQ |
Oct 12, 16:00
99.40
+0.14
(+0.14%)
After-Hours: 20:00
Kodiak Sciences Free Cash Flow (Quarterly) : -46.59M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -46.59M |
| March 31, 2026 | -40.95M |
| December 31, 2025 | -39.42M |
| September 30, 2025 | -32.94M |
| June 30, 2025 | -34.81M |
| March 31, 2025 | -29.35M |
| December 31, 2024 | -30.19M |
| September 30, 2024 | -21.36M |
| June 30, 2024 | -26.54M |
| March 31, 2024 | -39.62M |
| December 31, 2023 | -59.72M |
| September 30, 2023 | -32.99M |
| June 30, 2023 | -43.43M |
| March 31, 2023 | -59.47M |
| December 31, 2022 | -60.69M |
| September 30, 2022 | -60.36M |
| June 30, 2022 | -71.32M |
| Date | Value |
|---|---|
| March 31, 2022 | -61.45M |
| December 31, 2021 | -69.89M |
| September 30, 2021 | -83.65M |
| June 30, 2021 | -50.61M |
| March 31, 2021 | -41.41M |
| December 31, 2020 | -32.16M |
| September 30, 2020 | -26.18M |
| June 30, 2020 | -13.97M |
| March 31, 2020 | -18.11M |
| December 31, 2019 | -11.45M |
| September 30, 2019 | -7.854M |
| June 30, 2019 | -13.07M |
| March 31, 2019 | -7.214M |
| December 31, 2018 | -8.865M |
| September 30, 2018 | |
| March 31, 2018 | -11.26M |
| December 31, 2017 | -4.947M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 521.80M |
| AbbVie, Inc. | 3.114B |
| Mirum Pharmaceuticals, Inc. | -69.28M |
| ACADIA Pharmaceuticals, Inc. | 95.69M |
| Alnylam Pharmaceuticals, Inc. | 292.04M |